Sunshine Biopharma (SBFM) Institutional Ownership $1.29 +0.04 (+3.20%) Closing price 04/21/2025 04:00 PM EasternExtended Trading$1.25 -0.04 (-2.79%) As of 05:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Sunshine Biopharma (NASDAQ:SBFM)CurrentInstitutional OwnershipPercentage41.98%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$34.04KNumber ofInstitutional Sellers(last 12 months)0 Get SBFM Insider Trade Alerts Want to know when executives and insiders are buying or selling Sunshine Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Sunshine Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/18/2025Connective Capital Management LLC11,345$34K0.0%N/A0.930% 2/13/2024Armistice Capital LLC2,130,000$578K0.0%+118.7%8.294% 11/15/2023Armistice Capital LLC974,000$312K0.0%-55.6%3.793% 5/17/2022Empery Asset Management LP450,450$1.10M5.2%N/A2.730% (Data available from 1/1/2016 forward) SBFM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SBFM shares? During the previous two years, the following institutional investors and hedge funds held shares of Sunshine Biopharma shares: Armistice Capital LLC ($578K), Connective Capital Management LLC ($34K).Learn more on SBFM's institutional investors. What percentage of Sunshine Biopharma stock is owned by institutional investors? 41.98% of Sunshine Biopharma stock is owned by institutional investors. Learn more on SBFM's institutional investor holdings. Which institutional investors have been buying Sunshine Biopharma stock? The following institutional investors have purchased Sunshine Biopharma stock in the last 24 months: Armistice Capital LLC ($1.16M), and Connective Capital Management LLC ($11.35K). How much institutional buying is happening at Sunshine Biopharma? Institutional investors have bought a total of 1,167,345 shares in the last 24 months. This purchase volume represents approximately $31.42M in transactions. Which Sunshine Biopharma major shareholders have been selling company stock? The following institutional investors have sold Sunshine Biopharma stock in the last 24 months: Armistice Capital LLC ($1.22M). How much institutional selling is happening at Sunshine Biopharma? Institutional investors have sold a total of 1,220,000 shares in the last 24 months. This volume of shares sold represents approximately $39.04M in transactions. Related Companies ABVC Institutional Ownership NRSN Institutional Ownership PHIO Institutional Ownership INAB Institutional Ownership CLRB Institutional Ownership ME Institutional Ownership MBRX Institutional Ownership UPXI Institutional Ownership IMNN Institutional Ownership PRPH Institutional Ownership This page (NASDAQ:SBFM) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredBiggest AI gains still ahead…? (Major announcement coming)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrade War Just Turned 3 Unknown Stocks Into Rocket FuelThe Real Catalyst Behind America’s Next Bull Run One overlooked sector is being completely repriced — and s...Insiders Exposed | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SBFM Stock Free SBFM Stock Alerts